Memorial Sloan Kettering Cancer Center
Dr. Mrinal Gounder, MD, is an internationally recognized, medical oncologist and holds dual appointment in sarcoma and early drug development (phase 1) programs at MSKCC. He specializes in developing new drugs in cancer with a specific focus on sarcoma. He is the principal investigator of several global clinical trials phase I – III evaluating investigational drugs in solid tumors and sarcomas. He was the global lead for the study that led to FDA approval of tazemetostat in sarcoma. His original research has been published in the New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, Nature Medicine, and others. His research contributions to drug development in rare cancers were recognized as the top 10 Advances of the Year in 2018 in the field of oncology. He is also the MSKCC Physician Ambassador to India and Asia, and is passionate about building collaborations to improve access to patient care and collaborate on education, graduate medical training, and advancing cancer research and clinical trials globally.
Disclosure information not submitted.
Friday, November 18, 2022
10:45 AM – 12:40 PM
Friday, November 18, 2022
11:50 AM – 12:10 PM
Friday, November 18, 2022
12:10 PM – 12:40 PM